JP2017525675A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525675A5 JP2017525675A5 JP2017500883A JP2017500883A JP2017525675A5 JP 2017525675 A5 JP2017525675 A5 JP 2017525675A5 JP 2017500883 A JP2017500883 A JP 2017500883A JP 2017500883 A JP2017500883 A JP 2017500883A JP 2017525675 A5 JP2017525675 A5 JP 2017525675A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- rotator cuff
- tendon
- polypeptide
- bmp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462022516P | 2014-07-09 | 2014-07-09 | |
| US62/022,516 | 2014-07-09 | ||
| PCT/US2015/039743 WO2016007742A1 (en) | 2014-07-09 | 2015-07-09 | Treating rotator cuff conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017525675A JP2017525675A (ja) | 2017-09-07 |
| JP2017525675A5 true JP2017525675A5 (enExample) | 2018-07-19 |
Family
ID=55064896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017500883A Pending JP2017525675A (ja) | 2014-07-09 | 2015-07-09 | 回旋筋腱板異常の処置 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10610570B2 (enExample) |
| EP (1) | EP3166624B1 (enExample) |
| JP (1) | JP2017525675A (enExample) |
| WO (1) | WO2016007742A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017011762A1 (en) | 2015-07-16 | 2017-01-19 | Mayo Foundation For Medical Education And Research | Treating rotator cuff conditions |
| JP2023501925A (ja) * | 2019-10-24 | 2023-01-20 | ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ | 筋線維断片を利用した回旋腱板療法 |
| US12310928B2 (en) | 2020-11-16 | 2025-05-27 | University Of Utah Research Foundation | Enthesis healing |
| WO2024015257A1 (en) * | 2022-07-15 | 2024-01-18 | Mayo Foundation For Medical Education And Research | Methods and materials for promoting bone growth |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US5939388A (en) * | 1986-07-01 | 1999-08-17 | Rosen; Vicki A. | Methods of administering BMP-5 compositions |
| DE69030172T2 (de) | 1990-01-26 | 1997-06-19 | Immunomedics Inc | Impfstoffe gegen Krebs und Infektionskrankheiten |
| EP2289536A1 (en) * | 1995-06-05 | 2011-03-02 | Genetics Institute, LLC | Use of bone morphogenetic proteins for healing and repair of connective tissue attachment |
| CN1966725A (zh) | 2001-10-31 | 2007-05-23 | 爱尔康公司 | 骨形态生发蛋白(bmp)、bmp受体和bmp结合蛋白及它们在诊断和治疗青光眼中的用途 |
| WO2004056305A2 (en) | 2002-12-18 | 2004-07-08 | Algorx | Administration of capsaicinoids |
| EP2514445B1 (en) | 2003-10-22 | 2018-07-18 | Encelle, Inc. | Bioactive hydrogel compositions for the regeneration of connective tissue |
| US20100150885A1 (en) | 2005-06-01 | 2010-06-17 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
| ES2664229T3 (es) * | 2006-06-30 | 2018-04-18 | Biomimetic Therapeutics, Llc | Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador |
| US8753391B2 (en) | 2007-02-12 | 2014-06-17 | The Trustees Of Columbia University In The City Of New York | Fully synthetic implantable multi-phased scaffold |
| US9161903B2 (en) * | 2008-10-31 | 2015-10-20 | Warsaw Orthopedic, Inc. | Flowable composition that hardens on delivery to a target tissue site beneath the skin |
| GB0908174D0 (en) | 2009-05-13 | 2009-06-24 | Isis Innovation | Steroid containing composition and uses thereof |
| JP2012126720A (ja) | 2010-11-26 | 2012-07-05 | Chiba Univ | コラーゲンの産生促進剤、プロテオグリカン産出促進剤及び軟骨細胞の遊走促進剤 |
| US20150064163A1 (en) * | 2011-09-02 | 2015-03-05 | Lifenet Health | BMP Peptides & Methods of Use |
| WO2017011762A1 (en) | 2015-07-16 | 2017-01-19 | Mayo Foundation For Medical Education And Research | Treating rotator cuff conditions |
-
2015
- 2015-07-09 US US15/321,767 patent/US10610570B2/en active Active
- 2015-07-09 WO PCT/US2015/039743 patent/WO2016007742A1/en not_active Ceased
- 2015-07-09 EP EP15818814.4A patent/EP3166624B1/en active Active
- 2015-07-09 JP JP2017500883A patent/JP2017525675A/ja active Pending
-
2020
- 2020-04-03 US US16/840,173 patent/US20200397864A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202202410B (en) | Rna particles comprising polysarcosine | |
| MX2025012669A (es) | Proteinas klotho recombinantes novedosas y composiciones y metodos que involucran a las mismas | |
| MX2023008626A (es) | Proteinas klotho recombinantes terapeuticas y composiciones y metodos que involucran a las mismas. | |
| AU2018240515A1 (en) | Nucleic acids encoding CRISPR-associated proteins and uses thereof | |
| MX359953B (es) | Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada. | |
| EA201200515A1 (ru) | Полипептиды и их применение | |
| WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
| MA40057A (fr) | Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants | |
| MX340541B (es) | Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio. | |
| WO2017011773A3 (en) | Codon-optimized nucleic acids encoding antibodies | |
| MX2016002152A (es) | Metodo para aumentar la expresion de proteinas codificadas por arn. | |
| NZ621868A (en) | Growth hormone polypeptides and methods of making and using same | |
| WO2017009843A3 (en) | Compositions, articles of manufacture and methods for treating cancer | |
| PE20130648A1 (es) | Tratamiento del sindrome de sanfilippo tipo b | |
| WO2014165607A3 (en) | Aromatic-cationic peptide formulations, compositions and methods of use | |
| RU2016152151A (ru) | Препарат, содержащий фактор viii и пептиды фактора фон виллебранда | |
| EA201892446A1 (ru) | Фармацевтическая композиция | |
| AR093365A1 (es) | Formulacion para polipeptidos | |
| AR095076A1 (es) | Péptidos y composiciones para el tratamiento de daño articular | |
| HK1211225A1 (en) | Injectable depot formulation comprising optically active tolvaptan and process of producing the same | |
| JP2017517561A5 (enExample) | ||
| WO2015108856A3 (en) | Methods for enhancing the delivery of active agents | |
| WO2018031730A3 (en) | Peptide inhibitors of phosphoglycerate mutase and methods of use | |
| ATE552271T1 (de) | Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon | |
| CO6160332A2 (es) | Agente para terapia y/o mejoramiento de coagulacion intravascular diseminada |